Take Your Trading To The Next Level. Get Started Here!

Biotech stocks jump on AbbVie deal to buy cancer drugmaker ImmunoGen for $10 billion

November 30, 2023 Comments Off

Other biotech companies developing ADCs, which are among the hottest areas in the pharmaceutical industry, jumped on the news of AbbVie’s buyout of ImmunoGen.